Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Angle Plc (AGLE)

London
Currency in GBP
Disclaimer
14.50
+0.50(+3.57%)
Closed

AGLE Price Commentary

Still buying after today's announcement.
Too cheap
Whilst there is no news the share price will drift off to the £1.00 region-its worth considering adding to holdings if the price sinks somewhat further towards the 80+region.
The prognosis for this share price is unbeleivable as the CEO is aiming to dominate the world with blood tests that find and deliver live cancer cells-so no more biopsies !The assumption is the USA FDA approve their M/C application which is expected towards the end of the year.Some ridiculous projections for the sp suggest circa £1500 yes thats one thousand five hundred pounds a share-because their is no competition -suggest check out the website for the full details of patients, posters and peer reviews.Of course the immediate share price will collapse and recover if no FDA approval-nevertheless a holding of a couple of thousand shares will give £3million in a very short time IF APPROVED.Many years of trading and I have never seen anything like this.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.